Tag: Healthcare Policy

House Democrats Push for ACA Tax Credit Extension Amid Rising U.S. Cost of Living

House Democrats initiate a discharge petition to extend Affordable Care Act tax credits as healthcare costs and living expenses climb nationally, highlighting legislative efforts to address the affordability crisis in the U.S.

Senate to Vote on Expiring ACA Premium Subsidies Amid Partisan Division

The Senate plans a vote this year on extending expiring ACA premium subsidies, a move crucial for healthcare affordability and insurance market stability, amid partisan debates over subsidy distribution methods.

Montana ACA Marketplace Faces Steep Premium Increases as Enhanced Subsidies Expire

Montana faces major health insurance premium hikes as enhanced ACA subsidies end in 2025, pressuring affordable coverage and fueling policy debates.

Humana Appeals Medicare Star Rating Dispute Amid Regulatory Changes

Humana appeals CMS Medicare Advantage star ratings dispute as federal courts and regulatory changes reshape payer compliance and bonus structures in the MA market.

The Rise and Implications of Viatical Settlements During the Early AIDS Crisis

Explore the historical emergence and market implications of viatical settlements during the AIDS crisis, highlighting regulatory and healthcare policy impacts in the U.S.

U.S. Healthcare and Insurance Outlook for 2026: AI, Policy, and Market Trends

Comprehensive 2026 outlook on U.S. healthcare and insurance sector covering AI adoption, Medicare Advantage growth, pharmaceutical scrutiny, market consolidations, and emerging health equity focus.

Rep. Fedorchak Proposes Consumer-Driven Fixes to Affordable Care Act

Rep. Julie Fedorchak outlines proposed reforms to the Affordable Care Act focusing on cross-state insurance sales, consumer choice, and pricing transparency to improve affordability and access.

CMS Updates Competitive Bidding Program for Durable Medical Equipment

CMS revises competitive bidding program for durable medical equipment, affecting supply contracts and patient access concerns within Medicare's medical device market.

Medicare Drug Price Negotiations Cut Costs for 15 Key Medications

New Medicare drug price negotiations reduce government costs on 15 high-spend medications, including cancer and diabetes treatments, saving $12 billion annually.

CMS Proposes Medicare Advantage Bonus Return, $13B Insurer Impact

CMS's Medicare Advantage proposal reintroduces the reward factor, affecting insurer payments by $13B, and phases out the inpatient-only list, impacting outpatient care and rural health strategies.